Komori
Other Disclosures2395SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.Information and Communications, Services and Others

Shin Nippon Biomedical Laboratories' greenhouse gas reduction targets have received SBTi certification

The greenhouse gas emissions reduction targets set by the Shin Nippon Biomedical Laboratories Group have received SBTi validation. The validated targets include reducing Scope 1 and 2 emissions by 52.62% by FY2034.

Worth reading
51Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
52.62
% reduction (Scope 1 and 2, FY2024 baseline)
Wording
Definitive
How definitive the wording is.

Announced details

Greenhouse gas emissions reduction targets
Applicable field (uses covered by this announcement)

Greenhouse gas emissions reduction, climate change response, sustainability

Launch dateValidation date: 15 September 2026 (actual)
What the company reported numerically
Quantitative Effects

Reduce Scope 1 and 2 greenhouse gas emissions by 52.62% by FY2034 from the FY2024 baseline. For Scope 3, 78.3% of suppliers and customers will set science-based targets by FY2031.

Relationship between the counterparty and the company
SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.2395
Relationship with the Company

SBTi validated the Shin Nippon Biomedical Laboratories Group's greenhouse gas emissions reduction targets.

CounterpartyScience Based Targets initiative(SBTi)

An organization that scientifically verifies and validates whether companies' greenhouse gas emissions reduction targets are aligned with the Paris Agreement's goal of limiting the rise in global temperatures to 1.5°C. Other information on its location, representative, capital, and year established is not disclosed.

Award/certification name

SBTi validation of greenhouse gas emissions reduction targets

Awarding / certifying body

Science Based Targets initiative(SBTi)

Impact on Business Performance

The impact on business performance is Not disclosed

The company does not address Contract Value / Offering price.

Source (materials cited by the company)

Science Based Targets initiative(SBTi)

Announced details
ItemDetails
Names of Products / Services CoveredGreenhouse gas emissions reduction targets
CounterpartyScience Based Targets initiative(SBTi)
Counterparty overviewAn organization that scientifically verifies and validates whether companies' greenhouse gas emissions reduction targets are aligned with the Paris Agreement's goal of limiting the rise in global temperatures to 1.5°C. Other information on its location, representative, capital, and year established is not disclosed.
Relationship with the CompanySBTi validated the Shin Nippon Biomedical Laboratories Group's greenhouse gas emissions reduction targets.
Launch dateValidation date: 15 September 2026 (actual)
Applicable areaGreenhouse gas emissions reduction, climate change response, sustainability
Award/certification nameSBTi validation of greenhouse gas emissions reduction targets
Awarding / certifying bodyScience Based Targets initiative(SBTi)
Quantitative EffectsReduce Scope 1 and 2 greenhouse gas emissions by 52.62% by FY2034 from the FY2024 baseline. For Scope 3, 78.3% of suppliers and customers will set science-based targets by FY2031.
Impact on Business PerformanceThe impact on business performance is Not disclosed
SourceScience Based Targets initiative(SBTi)
Items this document does not state (7)
Contract ValueOffering priceContract DateRegistration number and expiry dateLocationLocation scaleUsage history

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The targets set were recognized as science-based greenhouse gas emissions reduction targets that meet SBTi criteria.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Shin Nippon Biomedical Laboratories' greenhouse gas reduction targets have received SBTi certification | SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. (2395) timely disclosure | Komori